<code id='020C7D21F9'></code><style id='020C7D21F9'></style>
    • <acronym id='020C7D21F9'></acronym>
      <center id='020C7D21F9'><center id='020C7D21F9'><tfoot id='020C7D21F9'></tfoot></center><abbr id='020C7D21F9'><dir id='020C7D21F9'><tfoot id='020C7D21F9'></tfoot><noframes id='020C7D21F9'>

    • <optgroup id='020C7D21F9'><strike id='020C7D21F9'><sup id='020C7D21F9'></sup></strike><code id='020C7D21F9'></code></optgroup>
        1. <b id='020C7D21F9'><label id='020C7D21F9'><select id='020C7D21F9'><dt id='020C7D21F9'><span id='020C7D21F9'></span></dt></select></label></b><u id='020C7D21F9'></u>
          <i id='020C7D21F9'><strike id='020C7D21F9'><tt id='020C7D21F9'><pre id='020C7D21F9'></pre></tt></strike></i>

          Home / Wikipedia / explore

          explore


          explore

          author:comprehensive    Page View:9681
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In